NCT03342352 2019-12-20
Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
Incyte Corporation
Phase 3 Withdrawn
Incyte Corporation
Bristol-Myers Squibb
SWOG Cancer Research Network
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC